HARTFORD, CT - MARCH 21, 2013 – Axinn announced Chad Landmon, Chair of the firm’s FDA practice group and Co-Chair of the intellectual property practice, has been named a 2013 Law360 “Rising Star” in the life sciences area. The national award recognizes top legal talent under the age of 40 in 24 practice areas.
At 38 years old, Mr. Landmon is recognized as a leading advocate for pharmaceutical companies before FDA and premier patent litigator and counselor on issues involving the development and marketing of generic drugs and human tissue products.
“We are very pleased that Chad has been recognized for his hard work in the complex areas of FDA regulatory and intellectual property matters involving life sciences products,” said Axinn founding partner Jim Veltrop. “The recognition is well-deserved.”
Law360 named 112 attorneys to its Rising Stars List for 2013, after its editorial team reviewed close to 1,000 nominees. Landmon was named as one of only three “Rising Stars” in the life sciences area. Winners will be profiled by Law360.
Mr. Landmon is well-known in the FDA community and advocates for clients before FDA, both informally and formally through FDA’s citizen petition process. He has obtained a number of key victories representing clients in suits involving the FDA. His victories include a recent ruling in a case involving client Watson Laboratories that has been cited as the first time a court ever ordered the FDA to approve a marketing application for a drug (WATSON LABORATORIES, INC. v. SEBELIUS Case 1:12-cv-01344-ABJ (D.D.C.).
Click here to view article.
Axinn combines the skills, experience and dedication of the world’s largest firms with the focus, responsiveness, efficiency and attention to client needs of the best boutiques. Axinn was established in the late 1990s by lawyers from premier Wall Street firms with a common vision, and has been joined by lawyers from the best firms and law schools who share that vision. The firm is devoted to providing the highest conceivable quality of service in three practice areas: antitrust, intellectual property and high-stakes litigation.